Total Payments
$152,690
2023 Payments
$195.01
Companies
10
Transactions
146
Medicare Patients
8,562
Medicare Billing
$456,547
Payment Breakdown by Category
Other$135,116 (88.5%)
Travel$14,219 (9.3%)
Food & Beverage$3,356 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $135,116 | 49 | 88.5% |
| Travel and Lodging | $14,219 | 50 | 9.3% |
| Food and Beverage | $3,356 | 47 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Pharma plc | $138,611 | 122 | $0 (2018) |
| Horizon Therapeutics plc | $13,671 | 14 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $106.06 | 2 | $0 (2018) |
| UCB, Inc. | $87.69 | 1 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $80.11 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $53.68 | 2 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $25.38 | 1 | $0 (2023) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.02 | 1 | $0 (2017) |
| CSL Behring | $18.72 | 1 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $15.47 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $195.01 | 3 | Horizon Therapeutics plc ($169.63) |
| 2022 | $167.80 | 2 | UCB, Inc. ($87.69) |
| 2021 | $59.87 | 2 | GlaxoSmithKline, LLC. ($41.15) |
| 2019 | $13,517 | 13 | Horizon Therapeutics plc ($13,502) |
| 2018 | $25,327 | 26 | Horizon Pharma plc ($25,209) |
| 2017 | $113,423 | 100 | Horizon Pharma plc ($113,402) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: KRYSTEXXA | ||||||
| 07/14/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $44.65 | General |
| Category: KRYSTEXXA | ||||||
| 05/15/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $25.38 | General |
| Category: PSYCHOLOGY | ||||||
| 11/11/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $87.69 | General |
| Category: Immunology | ||||||
| 02/25/2022 | Janssen Scientific Affairs, LLC | TREMFYA (Drug), SIMPONI ARIA, STELARA | Food and Beverage | In-kind items and services | $80.11 | General |
| Category: Immunology | ||||||
| 09/20/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $41.15 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2021 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 12/02/2019 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Endocrinology | ||||||
| 11/19/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $3,264.00 | General |
| Category: KRYSTEXXA | ||||||
| 11/19/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $97.88 | General |
| Category: KRYSTEXXA | ||||||
| 06/20/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $3,264.00 | General |
| Category: KRYSTEXXA | ||||||
| 06/20/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $247.08 | General |
| Category: KRYSTEXXA | ||||||
| 06/20/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $118.29 | General |
| Category: KRYSTEXXA | ||||||
| 06/20/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $7.00 | General |
| Category: KRYSTEXXA | ||||||
| 06/10/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $200.00 | General |
| Category: KRYSTEXXA | ||||||
| 03/20/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $3,264.00 | General |
| Category: KRYSTEXXA | ||||||
| 03/20/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $7.00 | General |
| Category: KRYSTEXXA | ||||||
| 02/01/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $2,448.00 | General |
| Category: KRYSTEXXA | ||||||
| 02/01/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $179.44 | General |
| Category: KRYSTEXXA | ||||||
| 01/31/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $405.00 | General |
| Category: KRYSTEXXA | ||||||
| 12/13/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Honoraria | Cash or cash equivalent | $2,448.00 | General |
| Category: KRYSTEXXA | ||||||
| 12/13/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: KRYSTEXXA | ||||||
| 11/27/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Honoraria | Cash or cash equivalent | $2,448.00 | General |
| Category: KRYSTEXXA | ||||||
| 11/27/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | Cash or cash equivalent | $111.91 | General |
| Category: KRYSTEXXA | ||||||
| 11/15/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Honoraria | Cash or cash equivalent | $3,264.00 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 147 | 282 | $28,200 | $9,326 |
| 2022 | 1 | 1,475 | 3,064 | $306,400 | $72,771 |
| 2021 | 1 | 3,390 | 7,522 | $752,200 | $182,221 |
| 2020 | 1 | 3,550 | 7,721 | $772,100 | $192,229 |
Total Patients
8,562
Total Services
18,589
Medicare Billing
$456,547
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 76881 | Complete ultrasound scan of joint | Office | 2023 | 147 | 282 | $28,200 | $9,326 | 33.1% |
| 76881 | Complete ultrasound scan of joint | Office | 2022 | 1,475 | 3,064 | $306,400 | $72,771 | 23.8% |
| 76881 | Complete ultrasound of arm or leg | Office | 2021 | 3,390 | 7,522 | $752,200 | $182,221 | 24.2% |
| 76881 | Complete ultrasound of joint of arm or leg | Office | 2020 | 3,550 | 7,721 | $772,100 | $192,229 | 24.9% |
About Dr. Anthony Anderson, MD
Dr. Anthony Anderson, MD is a Diagnostic Ultrasound healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760445514.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Anderson, MD has received a total of $152,690 in payments from pharmaceutical and medical device companies, with $195.01 received in 2023. These payments were reported across 146 transactions from 10 companies. The most common payment nature is "Honoraria" ($135,116).
As a Medicare-enrolled provider, Anderson has provided services to 8,562 Medicare beneficiaries, totaling 18,589 services with total Medicare billing of $456,547. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Ultrasound
- Other Specialties Rheumatology
- Location Greensboro, NC
- Active Since 04/11/2006
- Last Updated 11/03/2025
- Taxonomy Code 2085U0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760445514
Products in Payments
- KRYSTEXXA (Drug) $138,611
- KRYSTEXXA (Biological) $13,671
- ORENCIA (Biological) $106.06
- Cimzia (Drug) $87.69
- TREMFYA (Drug) $80.11
- BENLYSTA (Biological) $41.15
- QELBREE (Drug) $25.38
- COSENTYX (Biological) $21.02
- Kcentra (Biological) $18.72
- Strensiq (Drug) $15.47
- SHINGRIX (Biological) $12.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.